How does the ICD recognize the type of arrhythmia? Tachyarrhythmia discrimination in modern transvenous cardioverter defibrillators
Modern cardioverter defibrillators apply different discrimination algorithms to differentiate between supraventricular arrhythmias and malignant ventricular arrhythmias, leading to a decrease in the rate of inappropriate ICD therapies. The two main groups of discrimination algorithms are single-cham...
| Published in: | Cardiologia Hungarica |
|---|---|
| Main Authors: | Flóra Diána Gausz, Zsolt Bári, Máté Vámos |
| Format: | Article |
| Language: | English |
| Published: |
Promenade Kft
2025-08-01
|
| Subjects: | |
| Online Access: | https://cardiologia.hungarica.eu/archive/2025-issues/2025-4-contents/how-does-the-icd-recognize-the-type-of-arrhythmia-tachyarrhythmia-discrimination-in-modern-transvenous-cardioverter-defibrillators |
Similar Items
Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort
by: Badder Kattih, et al.
Published: (2022-10-01)
by: Badder Kattih, et al.
Published: (2022-10-01)
Arrhythmia Detection in Atrioventricular, Single-Lead, Floating Atrial Dipole ICD Systems Compared with Conventional Single- and Dual-Chamber Defibrillators
by: Flora Diana Gausz, et al.
Published: (2024-12-01)
by: Flora Diana Gausz, et al.
Published: (2024-12-01)
Benefit of implantable cardioverter defibrillator use in Japanese patients based on modified MADIT‐ICD benefit score
by: Toshinori Chiba, et al.
Published: (2025-02-01)
by: Toshinori Chiba, et al.
Published: (2025-02-01)
Lead Extractions are not Necessarily Required in the Treatment of Cases with Local Complications Unproven Resional/systemic Infection at the Pacemaker/ implantable Cardioverter Defibrillator (ICD) Site
by: Ryoji Kishi, MD, et al.
Published: (2005-01-01)
by: Ryoji Kishi, MD, et al.
Published: (2005-01-01)
Twiddler's syndrome: An unusual cause of repeated shocks by implantable cardioverter-defibrillator in an asymptomatic patient
by: Ahmad Jabri, et al.
Published: (2019-01-01)
by: Ahmad Jabri, et al.
Published: (2019-01-01)
Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system
by: Konstantinos Kossidas, MD, FHRS, et al.
Published: (2017-12-01)
by: Konstantinos Kossidas, MD, FHRS, et al.
Published: (2017-12-01)
Factors Associated With Non-Uptake of Implantable Cardioverter-Defibrillator (ICD) Among Eligible Patients at a Tertiary Hospital in Kenya
by: Emmanuel Oluoch, et al.
Published: (2024-08-01)
by: Emmanuel Oluoch, et al.
Published: (2024-08-01)
Implantable Cardioverter Defibrillator Tachycardia Therapies: Past, Present and Future Directions
by: Andrew M. Leong, et al.
Published: (2024-03-01)
by: Andrew M. Leong, et al.
Published: (2024-03-01)
Real-World Efficacy and Safety of the Subcutaneous Implantable Cardioverter Defibrillator: Insights from the GASP Registry
by: Nikias Milaras, et al.
Published: (2025-06-01)
by: Nikias Milaras, et al.
Published: (2025-06-01)
Risk factors for the first and second inappropriate implantable cardioverter-defibrillator therapy
by: Nobuhiro Nishii, et al.
Published: (2021-06-01)
by: Nobuhiro Nishii, et al.
Published: (2021-06-01)
Postoperative intravenous patient‐controlled analgesia improves pain management after subcutaneous implantable defibrillator implantation
by: Kenta Tsutsui, et al.
Published: (2024-04-01)
by: Kenta Tsutsui, et al.
Published: (2024-04-01)
Routine DFT testing in patients undergoing ICD implantation does not improve mortality: A systematic review and meta‐analysis
by: Munish Kannabhiran, et al.
Published: (2018-12-01)
by: Munish Kannabhiran, et al.
Published: (2018-12-01)
Sex differences in ICDs for primary prevention: Time to include women in ICD trials!
by: Luisa Allen Ciuffo, et al.
Published: (2022-04-01)
by: Luisa Allen Ciuffo, et al.
Published: (2022-04-01)
The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections
by: L. Castro, et al.
Published: (2017-11-01)
by: L. Castro, et al.
Published: (2017-11-01)
“I don’t know exactly what you’re referring to”: the challenge of values elicitation in decision making for implantable cardioverter-defibrillators
by: Carroll SL, et al.
Published: (2018-09-01)
by: Carroll SL, et al.
Published: (2018-09-01)
Subcutaneous implantable cardioverter‐defibrillator: a systematic review of comparative effectiveness and safety
by: Sarah Wolf, et al.
Published: (2023-04-01)
by: Sarah Wolf, et al.
Published: (2023-04-01)
Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators
by: Sajya M. Singh, BS, et al.
Published: (2021-08-01)
by: Sajya M. Singh, BS, et al.
Published: (2021-08-01)
An inappropriately–appropriate ICD therapy: What is the mechanism and what interventions can be done?
by: Athanasios Saplaouras, et al.
Published: (2023-10-01)
by: Athanasios Saplaouras, et al.
Published: (2023-10-01)
Catastrophic implantable cardioverter-defibrillator misclassification of ventricular tachycardia
by: Zhafran Veliawan, et al.
Published: (2024-05-01)
by: Zhafran Veliawan, et al.
Published: (2024-05-01)
Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease
by: Christos Zormpas, et al.
Published: (2021-04-01)
by: Christos Zormpas, et al.
Published: (2021-04-01)
A case of pioneering subcutaneous implantable cardioverter defibrillator intervention in Timothy syndrome
by: Zixi Zhang, et al.
Published: (2024-11-01)
by: Zixi Zhang, et al.
Published: (2024-11-01)
Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation
by: Omid Kiamanesh, MD, et al.
Published: (2015-07-01)
by: Omid Kiamanesh, MD, et al.
Published: (2015-07-01)
Stretch, Injury and Inflammation Markers Evaluation to Predict Clinical Outcomes After Implantable Cardioverter Defibrillator Therapy in Heart Failure Patients With Metabolic Syndrome
by: Celestino Sardu, et al.
Published: (2018-06-01)
by: Celestino Sardu, et al.
Published: (2018-06-01)
Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation
by: T. O. Bessonova, et al.
Published: (2022-04-01)
by: T. O. Bessonova, et al.
Published: (2022-04-01)
ICD Outcome in Pediatric Cardiomyopathies
by: Massimo Stefano Silvetti, et al.
Published: (2022-01-01)
by: Massimo Stefano Silvetti, et al.
Published: (2022-01-01)
Outcomes in Brugada Syndrome Patients With Implantable Cardioverter-Defibrillators: Insights From the SGLT2 Registry
by: Sharen Lee, et al.
Published: (2020-03-01)
by: Sharen Lee, et al.
Published: (2020-03-01)
Influence of myopotential interference on the Wavelet discrimination algorithm in implantable cardioverter-defibrillator
by: Kazuya Mizukami, MD, PhD, et al.
Published: (2017-06-01)
by: Kazuya Mizukami, MD, PhD, et al.
Published: (2017-06-01)
Sudden Cardiac Death in Children Affected by Cardiomyopathies: An Update on Risk Factors and Indications at Transvenous or Subcutaneous Implantable Defibrillators
by: Valeria Rella, et al.
Published: (2020-04-01)
by: Valeria Rella, et al.
Published: (2020-04-01)
Prognostic impact of implantable cardioverter defibrillators and associated adverse events in patients with continuous flow left ventricular assist devices
by: Jonas Pausch, et al.
Published: (2023-06-01)
by: Jonas Pausch, et al.
Published: (2023-06-01)
Perioperative Sensor and Algorithm Programming in Patients with Implanted ICDs and Pacemakers for Cardiac Resynchronization Therapy
by: Alexander Niedermeier, et al.
Published: (2021-12-01)
by: Alexander Niedermeier, et al.
Published: (2021-12-01)
Contemporary Management and Prognostic Factors of Arrhythmia Recurrence in Patients with High-Energy Discharge of Cardiac Implantable Electronic Devices
by: Zofia Kampka, et al.
Published: (2024-10-01)
by: Zofia Kampka, et al.
Published: (2024-10-01)
Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
by: Yuki Konno, et al.
Published: (2025-04-01)
by: Yuki Konno, et al.
Published: (2025-04-01)
Implantable Cardioverter Defibrillator in Primary and Secondary Prevention of SCD—What We Still Don′t Know
by: Andreea Maria Ursaru, et al.
Published: (2022-04-01)
by: Andreea Maria Ursaru, et al.
Published: (2022-04-01)
Anatomical considerations for the nontransvenous implantable cardioverter-defibrillator implantation: A cadaver-based analysis
by: Peter Khalil, MD, FHRS, et al.
Published: (2025-10-01)
by: Peter Khalil, MD, FHRS, et al.
Published: (2025-10-01)
Balanced-force shim system for correcting magnetic-field inhomogeneities in the heart due to implanted cardioverter defibrillators
by: Mirko Hrovat, et al.
Published: (2024-02-01)
by: Mirko Hrovat, et al.
Published: (2024-02-01)
Bioelectrical impedance analysis of body composition: influence of a newly implanted cardiac device
by: Pinto Luiz Wellington, et al.
Published: (2017-07-01)
by: Pinto Luiz Wellington, et al.
Published: (2017-07-01)
Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
by: Yasuhisa Nakao, et al.
Published: (2020-03-01)
by: Yasuhisa Nakao, et al.
Published: (2020-03-01)
Current status of implantable defibrillator devices in patients with left ventricular dysfunction — The first report from the online registry database
by: Akihiko Shimizu, MD, et al.
Published: (2008-01-01)
by: Akihiko Shimizu, MD, et al.
Published: (2008-01-01)
Relation of Supraventricular Arrhythmias Detected by Implantable Cardioverter Defibrillator and Air Pollutants
by: Javad Shahabi, et al.
Published: (2024-08-01)
by: Javad Shahabi, et al.
Published: (2024-08-01)
The effect of air pollution on ventricular arrhythmias in patients with implantable cardioverter defibrillator
by: Javad Shahabi, et al.
Published: (2023-01-01)
by: Javad Shahabi, et al.
Published: (2023-01-01)
Similar Items
-
Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort
by: Badder Kattih, et al.
Published: (2022-10-01) -
Arrhythmia Detection in Atrioventricular, Single-Lead, Floating Atrial Dipole ICD Systems Compared with Conventional Single- and Dual-Chamber Defibrillators
by: Flora Diana Gausz, et al.
Published: (2024-12-01) -
Benefit of implantable cardioverter defibrillator use in Japanese patients based on modified MADIT‐ICD benefit score
by: Toshinori Chiba, et al.
Published: (2025-02-01) -
Lead Extractions are not Necessarily Required in the Treatment of Cases with Local Complications Unproven Resional/systemic Infection at the Pacemaker/ implantable Cardioverter Defibrillator (ICD) Site
by: Ryoji Kishi, MD, et al.
Published: (2005-01-01) -
Twiddler's syndrome: An unusual cause of repeated shocks by implantable cardioverter-defibrillator in an asymptomatic patient
by: Ahmad Jabri, et al.
Published: (2019-01-01)
